Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Buprenorphine Transdermal System in Chronic Nonmalignant Pain
NCT00312195Phase 3Completed
- Sponsor
- Purdue Pharma
- Start
- Mar 2001
- Primary completion
- Jul 2001
- Modality
- Orthosteric Ligands, Inhalation Devices
- Countries
- 2
01
Overview
A Phase 3 trial of v1003 in Chronic non-malignant pain (CNMP), sponsored by Purdue Pharma. Started Mar 2001; status: completed.
02
Drugs
v1003
03
Conditions
Chronic non-malignant pain (CNMP)
Beyond the preview
Go deeper on NCT00312195.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00312195.